'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
NCT04553926
·
clinicaltrials.gov ↗
COMPLETED
Status
661
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Sponsor
AstraZeneca